featured
2014 Top Stories in Eye Care: Uveitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Levy-Clarke G, Jabs DA, Read RW, et al. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121(3):785-796.
- Pelegrin L, Jakob E, Schmidt-Bacher A, et al. Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement. J Rheumatol. 2014;41(1):84-90.
- Maya JR, Sadiq MA, Zapata LJ, et al. Emerging therapies for noninfectious uveitis: what may be coming to the clinics. J Ophthalmol. 2014;2014:310329. http://www.hindawi.com/journals/joph/2014/310329/
- Papo M, Bielefeld P, Vallet H, et al. Tocilizumab in severe and refractory non-infectious uveitis. Clin Exp Rheumatol. 2014;32(4 Suppl 84):S75-S79.
- Yates WB, Vajdic CM, Na R, et al. Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study [published online ahead of print October 10, 2014]. Ophthalmology. doi: 10.1016/j.ophtha.2014.08.024.
- Artornsombudh P, Pistilli M, Foster CS, et al. Factors predictive of remission of new-onset anterior uveitis. Ophthalmology. 2014;121(3):778-784.
- Ostheimer TA, Burkholder BM, Leung TG, et al. Tattoo-associated uveitis. Am J Ophthalmol. 2014;158(3):637-643.